Hikma, Sciecure Pharma ink deal for niche injectable anti-viral medicinesHikma expects its deal with Sciecure will expand its pipeline of niche products. Lupin's generic Onfi gets FDA approvalLupin has received the Food and Drug Administration's green light for generic Onfi, which had a market value of roughly $260.2 million. Slayback gets FDA nod for generic Makena The Food and Drug Administration has approved Slayback Pharma's generic Makena, which is available in a multidose vial. Learning the management side of business Susan Novotny-Cannata explains why attaining a PharmD and an MBA is a win-win situation for students and their employers. New York City pharmacies banned from selling cigarettes A bill signed by NYC Mayor Bill de Blasio in 2017 that prohibits New York City pharmacies from selling cigarettes and other tobacco products took effect Jan. 1. HealthWarehouse.com implements Innovation's PharmASSIST Healthwarehouse.com credits Innovation's PharmASSIST for gains in Rx production, patient-related services and financial status. Teva introduces generic Elidel Teva's generic Elidel cream is available in three dosage strengths for atopic dermatitis. Stemline Therapeutics gets FDA green light for Elzonris The Food and Drug Administration has approved the first treatment for BPDCN, a rare blood disease. Shire gets FDA’s blessing for Motegrity Shire plans to launch Motegrity for chronic idiopathic constipation in 2019. Dr. Reddy’s launches 2 generics Dr. Reddy's is launching generic Renvela and Aggrenox, which had a market value of about $101 million and $182 million, respectively. First Previous 525 526 527 528 529 Next Last
